Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Published in: Osteoporosis International 4/2015

01-04-2015 | Letter

Undercarboxylated osteocalcin may be an attractive marker of teriparatide treatment in RA patients: response to Mokuda

Authors: K. Ebina, J. Hashimoto, K. Shi, M. Kashii, M. Hirao, H. Yoshikawa

Published in: Osteoporosis International | Issue 4/2015

Login to get access

Excerpt

Dear Editor, …
Literature
1.
2.
Ebina K, Hashimoto J, Shi K, Kashii M, Hirao M, Yoshikawa H (2014) Comparison of the effect of 18-month daily teriparatide administration on patients with rheumatoid arthritis and postmenopausal osteoporosis patients. Osteoporos Int 25:2755–2765. doi:10.​1007/​s00198-014-2819-x CrossRefPubMed
3.
Booth SL, Centi A, Smith SR, Gundberg C (2013) The role of osteocalcin in human glucose metabolism: marker or mediator? Nat Rev Endocrinol 9:43–55CrossRefPubMed
4.
Mokuda S, Sawada N, Matoba K, Yamada A, Onishi M, Okuda Y, Jouyama K, Murata Y, Takasugi K (2012) Serum undercarboxylated osteocalcin level increases with 48 weeks of teriparatide treatment in pre-treated elderly rheumatoid arthritis patients who use anti-resorptive drugs. J Endocrinol Invest 35:796–799CrossRefPubMed
Metadata
Title
Undercarboxylated osteocalcin may be an attractive marker of teriparatide treatment in RA patients: response to Mokuda
Authors
K. Ebina
J. Hashimoto
K. Shi
M. Kashii
M. Hirao
H. Yoshikawa
Publication date
01-04-2015
Publisher
Springer London
Published in
Osteoporosis International / Issue 4/2015
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-014-2993-x

Other articles of this Issue 4/2015

Osteoporosis International 4/2015 Go to the issue

Original Article

Does fetal smoke exposure affect childhood bone mass? The Generation R Study

Erratum

Erratum to: Efficacy of combined treatment with alendronate (ALN) and eldecalcitol, a new active vitamin D analog, compared to that of concomitant ALN, vitamin D plus calcium treatment in Japanese patients with primary osteoporosis

Original Article

Accelerated bone loss and increased post-fracture mortality in elderly women and men

Original Article

The social gradient of fractures at any skeletal site in men and women: data from the Geelong Osteoporosis Study Fracture Grid

Original Article

Calcium intake and bone mineral density as an example of non-linearity and threshold analysis

Case Report

Bone histomorphometry in a long-term hemodialysis patient with hypoparathyroidism and sarcoidosis